Liraglutide, a glucagon-like peptide-1 analog, induce autophagy and senescence in HepG2 cells

European Journal of Pharmacology
Gabriele Catyana KrauseJarbas Rodrigues de Oliveira

Abstract

It has been reported that glucagon-like peptide-1 (GLP-1) agents have been associated with both the increased risk of cancer and inhibition of tumor growth and metastases. The aim of this study is to evaluate the effect of liraglutide on hepatocellular carcinoma cells - HepG2. Cytometry was used to evaluate mechanism related to decreased cell proliferation. Nuclear staining and morphometric analysis were also used to verify the process that was taking place after treatment with liraglutide, and in order to better understand the mechanism, TGF-β1 was performed. HepG2 cells decreased proliferation after liraglutide treatment without altering oxidative stress levels. Liraglutide was able to induce autophagy and senescence through the increase of TGF-β1 which possibly explains the growth decrease. We have demonstrated that liraglutide has an antiproliferative effect in HepG2 cells inducing autophagy and senescence by the increase of TGF-β1.

References

Jun 13, 2001·Oncogene·C A Boulanger, G H Smith
Jan 16, 2002·Current Opinion in Genetics & Development·Lalage M Wakefield, Anita B Roberts
Sep 24, 2004·Cell Biochemistry and Function·Ganesaratnam K BalendiranDeborah Fraser
Sep 9, 2005·Nature Reviews. Cancer·Yasuko KondoSeiji Kondo
Sep 24, 2005·Cell·Sophie PattingreBeth Levine
Aug 5, 2006·Annals of the New York Academy of Sciences·Patricia L Brubaker
Feb 29, 2008·Nature·Noboru MizushimaDaniel J Klionsky
Jan 28, 2009·Apoptosis : an International Journal on Programmed Cell Death·Avital Eisenberg-Lerner, Adi Kimchi
Dec 17, 2009·British Journal of Clinical Pharmacology·Lisbeth V JacobsenMilan Zdravkovic
Jan 5, 2010·Current Opinion in Cell Biology·Andrew Rj Young, Masashi Narita
Mar 13, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nitika Arora GuptaFrank A Anania
Apr 2, 2010·Nature Reviews. Drug Discovery·Daniel J DruckerPeter Kirkpatrick
Jun 10, 2010·Critical Reviews in Eukaryotic Gene Expression·Hongyu Zhou, Shile Huang
Jun 29, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Serif SenturkMehmet Ozturk
Jul 16, 2010·Nature Reviews. Gastroenterology & Hepatology·Ju Dong Yang, Lewis R Roberts
Jul 21, 2010·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·E TomasJ F Habener
Feb 22, 2011·Gastroenterology·Michael ElashoffPeter C Butler
Mar 29, 2011·Pharmacology & Therapeutics·Jean M Mulcahy Levy, Andrew Thorburn
Jun 4, 2011·Breast Cancer Research and Treatment·Hagai LigumskyTami Rubinek
Oct 14, 2011·The New England Journal of Medicine·Hashem B El-Serag
Apr 25, 2012·Cancer Causes & Control : CCC·Adedayo A OnitiloSuhail A Doi
Nov 21, 2012·Diabetes, Obesity & Metabolism·K TatarkiewiczD Roy
May 8, 2014·American Journal of Physiology. Endocrinology and Metabolism·Hejun ZhaoTianpei Hong
Aug 9, 2016·Molecular and Cellular Endocrinology·Wenjing HeHaipeng Xiao

❮ Previous
Next ❯

Citations

May 6, 2020·Investigational New Drugs·Elisa Feller Gonçalves da SilvaJarbas Rodrigues de Oliveira

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
T Taminato
Nihon rinsho. Japanese journal of clinical medicine
T TaminatoS Nishi
Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns
Chuan-An ShenLin Zhang
© 2022 Meta ULC. All rights reserved